North American Neuromodulation Society

10/07/2026

See what’s ahead at NANS 2027. 🔬 🧠

Join the neuromodulation community Jan. 21–24 in Las Vegas for cutting-edge science, emerging technologies, practical education, and the conversations shaping what comes next for the field.

Register by Oct. 27 to save with Early Bird rates: www.nans.org/registration

Explore the program and make your plans for .

Register now for NANS 2027 Annual Meeting January 21–24, 2027 at Caesars Palace, Las Vegas, NV.

10/06/2026

🌟 NANS Member Spotlight: Jeff Arle, MD, PhD, FAANS, FCNS

A NANS member since 2005, Dr. Arle has built a career combining neuroscience, engineering and clinical care—and continues to contribute to the NANS community as an Annual Meeting presenter and invited speaker. 👏

Discover what sparked his interest in neuromodulation, his perspective on the NANS community and more.

Read more: https://www.nans.org/team/jeff-arle-md-phd-faans-fcns/

09/28/2026

The fall issue of PULSE has arrived! 🍂

Catch up on NANS news, hear from fellow members, and get a preview of what’s ahead at NANS 2027.

Want full access to PULSE and the chance to submit content for a future issue? Join NANS and add your voice to the conversation.

✉️ Read the issue: Members can check their inbox!
✔️ Become a member: www.nans.org/join

09/24/2026

Where the evidence ends, the conversation begins.

At NANS 2027, experts from across the field will examine the gray areas of neuromodulation—challenging assumptions, weighing differing perspectives, and tackling questions without one clear answer.

Join conversations on evidence and bias, PNS, AI and large language models, multimodal neuromodulation, and more.

📍 Las Vegas, Nevada
📅 January 21–24, 2027

Register today for the best value: https://l.feathr.co/NANS2027Reg

09/22/2026

NANS is advocating for greater access to peripheral nerve stimulation (PNS) for patients living with chronic pain.

In comments submitted to the Blue Cross Blue Shield Association, NANS urged recognition of PNS as a medically necessary treatment option for appropriately selected patients.

Today’s PNS therapies include multiple FDA-cleared platforms backed by a growing body of clinical evidence. As a non-opioid treatment option, PNS can offer patients another pathway for managing chronic pain and, for some, potentially reduce reliance on long-term medications or more invasive procedures.

Read the full NANS comment letter: https://ow.ly/BKA950ZQhrS

09/17/2026

📣 NANS has published a new evidence-based clinical practice guideline on peripheral nerve stimulation (PNS) for chronic pain.

Because PNS is not a single intervention with a uniform evidence base, the guideline takes an indication-specific approach—evaluating evidence by pain condition, anatomic region, neural target, stimulation mechanism, and temporary vs. permanent systems.

Grade A support for PNS includes:
• Hemiplegic shoulder pain
• Lower-extremity post-amputation pain
• Persistent spinal pain syndrome type I (PSPS-T1)

For PSPS-T1, the guideline further distinguishes between sensory stimulation of the lumbar medial branch nerves for non-surgical axial low-back pain and bilateral L2 medial branch motor stimulation in patients with documented multifidus dysfunction.

Read the publication: https://ow.ly/FOcN50ZOMug

09/15/2026

What ideas could help shape the future of neural interfaces?

There are just a few weeks left to submit a proposal for Neural Interfaces 2027. We’re looking for innovative perspectives spanning clinical applications, neural engineering, AI, emerging technologies, translation, ethics and more.

Bring your research, ideas and expertise to the conversation.

📅 Submit by October 12, 2026, at 1:00 PM CDT
📍 Neural Interfaces 2027 | May 20–22 | Arlington, VA

Explore the topics and submit: https://www.nans.org/neural-interfaces/

09/14/2026

NANS is advocating for Medicare payment policies that protect patient access, support physician practices, and encourage continued innovation in neuromodulation and pain management.

In response to the proposed 2027 Medicare Physician Fee Schedule, NANS raised concerns about declining physician payment, changes to practice expense methodology, Modifier 25 payment reductions, and revisions to remote monitoring reimbursement.

NANS urged CMS to consider the specialty-level impact of these changes and ensure Medicare policies support sustainable practices and access to high-quality, innovative care.

🔗 Read NANS’ comment letter: https://www.nans.org/news/nans-advocates-for-patient-access-and-fair-medicare-payment-in-2027-cms-comment-letter/

09/11/2026

🚨 Applications are due Tuesday, September 15!

There are just days left to apply for the NANS/ION Early Stage Investigator Research Grant.

NANS and the Institute of Neuromodulation (ION) will award two grants of up to $25,000 each to support early-stage investigators pursuing:

🧠 Brain-related neuromodulation research
🔬 Pain or spine-related neuromodulation research

Recipients will also receive mentorship from experienced investigators to help advance their research and careers.

Don’t let the deadline pass—submit your application by Tuesday, September 15.

🔗 Apply now: https://www.nans.org/ion/ -grant

09/10/2026

🎉 Registration & Housing for NANS 2027 are officially OPEN!

The countdown to Las Vegas starts now. Join us January 21–24, 2027, as the neuromodulation community comes together at Caesars Palace for Neuromodulation Without Boundaries.

Explore the latest science, expand your skills, connect with colleagues and experience what’s next for the field.

✅ Register for NANS 2027
🏨 Reserve your hotel room
📅 Start planning your meeting experience

Register and book your housing: https://l.feathr.co/NANS2027Reg

Join NANS in Las Vegas, Nevada for four days of groundbreaking education, interactive sessions, and unmatched networking opportunities.